Onconetix, Inc.
ONCO
$0.81
-$0.03-3.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -83.94% | -78.84% | -57.36% | -25.36% | -84.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -83.94% | -78.84% | -57.36% | -25.36% | -84.89% |
| Cost of Revenue | -64.44% | -58.60% | 7.50% | -88.45% | -94.04% |
| Gross Profit | -93.90% | -103.71% | -62.47% | 155.12% | -29.99% |
| SG&A Expenses | 47.39% | 21.81% | -42.83% | -11.38% | -31.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.22% | 20.45% | -40.95% | -22.27% | -48.69% |
| Operating Income | -67.35% | -26.56% | 35.02% | 21.80% | 36.63% |
| Income Before Tax | -20.86% | 50.68% | 118.68% | -126.16% | 83.36% |
| Income Tax Expenses | -- | -- | 100.05% | -- | -- |
| Earnings from Continuing Operations | -20.86% | 50.68% | 119.26% | -129.50% | 83.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.86% | 50.68% | 119.26% | -129.50% | 83.42% |
| EBIT | -67.35% | -26.56% | 35.02% | 21.80% | 36.63% |
| EBITDA | -67.62% | -26.59% | 31.02% | 15.39% | 30.17% |
| EPS Basic | 99.46% | -- | -- | -- | -- |
| Normalized Basic EPS | 99.24% | -- | -- | -- | -- |
| EPS Diluted | 99.46% | -- | -- | -- | -- |
| Normalized Diluted EPS | 99.24% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 19,573.68% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 19,573.68% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |